Use of real-world evidence for reimbursement in brazilian public sector: an analysis of submissions in neurology and rheumatology
Value in Health(2022)
Abstract
Real world evidence (RWE) provides clinical insights and is also essential in the development of decision-analytic models to evaluate the cost-effectiveness of a technology. This information is often relevant for reimbursement decision-making. We aim to explore the current uses of RWE in the Brazilian public healthcare system for neurology and rheumatology areas, summarize key concerns raised by payers and identify opportunities for better use of RWE for coverage decisions.
MoreTranslated text
Key words
brazilian public sector,reimbursement,rheumatology,neurology,public sector,real-world
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined